Paresh Dandona, MD, PhD — who did the first pilot studies on how drugs developed for Type 2 diabetes patients might benefit adults with Type 1 diabetes — is launching a major, interventional study with 114 patients in Buffalo and Glasgow, Scotland.
Twelve projects and their researchers were recognized as best in their respective categories during the Department of Medicine’s sixth annual Research Day.
Research led by Paresh Dandona, MD, PhD, has shown that adding liraglutide to insulin treatment for patients with Type 1 diabetes provides health benefits.
Fifty-four exemplary medical students, residents, fellows and faculty members have been inducted into the University at Buffalo’s Richard Sarkin Medical Emeritus Faculty Chapter of the Gold Humanism Honor Society (GHHS).
Paresh Dandona, MD, PhD, has led research showing that taking a fiber supplement can help patients with Type 2 diabetes boost their insulin secretion — even after eating a high-fat, high-carbohydrate meal.
A global study led by Paresh Dandona, MD, PhD, found a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels.
